| Carbohydrate supramolecular chemistry: Beyond the multivalent effect M González-Cuesta, CO Mellet, JMG Fernández Chemical Communications 56 (39), 5207-5222, 2020 | 91 | 2020 |
| Bicyclic picomolar OGA inhibitors enable chemoproteomic mapping of its endogenous post-translational modifications M Gonzalez-Cuesta, P Sidhu, RA Ashmus, A Males, C Proceviat, ... Journal of the American Chemical Society 144 (2), 832-844, 2022 | 20 | 2022 |
| Trifaceted Mickey Mouse Amphiphiles for Programmable Self‐Assembly, DNA Complexation and Organ‐Selective Gene Delivery AI Carbajo‐Gordillo, M González‐Cuesta, JL Jimenez Blanco, JM Benito, ... Chemistry–A European Journal 27 (36), 9429-9438, 2021 | 14 | 2021 |
| sp2-Iminosugars targeting human lysosomal β-hexosaminidase as pharmacological chaperone candidates for late-onset Tay-Sachs disease M González-Cuesta, I Herrera-González, MI García-Moreno, RA Ashmus, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 1364-1374, 2022 | 11 | 2022 |
| Multivalent glycoligands with lectin/enzyme dual specificity: Self-deliverable glycosidase regulators M González-Cuesta, D Goyard, E Nanba, K Higaki, JMG Fernández, ... Chemical Communications 55 (85), 12845-12848, 2019 | 8 | 2019 |
| Serine-/Cysteine-Based sp2-Iminoglycolipids as Novel TLR4 Agonists: Evaluation of Their Adjuvancy and Immunotherapeutic Properties in a Murine Model of Asthma M González-Cuesta, ACY Lai, PY Chi, IL Hsu, NT Liu, KC Wu, ... Journal of medicinal chemistry 66 (7), 4768-4783, 2023 | 4 | 2023 |
| Stereoselective Synthesis of Nojirimycin α-C-Glycosides from a Bicyclic Acyliminium Intermediate: A Convenient Entry to N,C-Biantennary Glycomimetics I Herrera-González, M González-Cuesta, MI García-Moreno, ... ACS omega 7 (26), 22394-22405, 2022 | 3 | 2022 |
| High‐Mannose Oligosaccharide Hemimimetics that Recapitulate the Conformation and Binding Mode to Concanavalin A, DC‐SIGN and Langerin I Herrera‐González, M González‐Cuesta, M Thépaut, E Laigre, D Goyard, ... Chemistry–A European Journal 30 (2), e202303041, 2024 | 2 | 2024 |
| Potent and Selective Cell‐Active Iminosugar Inhibitors of Human α‐N‐Acetylgalactosaminidase (α‐NAGAL) RA Ashmus, Y Wang, M González‐Cuesta, DT King, B Tiet, X Chen, ... Chemistry–A European Journal 29 (44), e202300982, 2023 | 2 | 2023 |
| Rational design of cell active C2-modified DGJ analogues for the inhibition of human α-galactosidase A (GALA) RA Ashmus, Y Wang, M Gonzalez-Cuesta, DT King, B Tiet, PA Gilormini, ... Organic & Biomolecular Chemistry 19 (37), 8057-8062, 2021 | 2 | 2021 |
| α-GalCer sp2-iminoglycolipid analogs as CD1d-dependent iNKT modulators: Evaluation of their immunotherapeutic potential in murine models of asthma and autoimmune hepatitis ACY Lai, M González-Cuesta, CH Ho, PY Chi, KC Wu, G Rocha, ... European Journal of Medicinal Chemistry 282, 117060, 2025 | | 2025 |
| 5-Aminohexahydro-6, 7, 8-trihydroxy-3H-oxazolo [3, 4-a] pyridin-3-one derivatives derivatives as TLR4 modulators for the treatment of immune diseases JM García Fernández, C Ortiz-Mellet, M González-Cuesta, ... | | 2023 |
| Multiantennary glycolipid mimetics JM García Fernández, C Ortiz-Mellet, M González-Cuesta, ... | | 2023 |
| Oligosaccharide complexes and uses J Moreno Herrero, H Haas, S Erbar, TB Stahl, JM García Fernández, ... | | 2023 |
| Nuevas estrategias para el estudio y tratamiento de enfermedades neurodegenerativas, la regulación del sistema inmune y el transporte de ácidos nucleicos basadas en carbohidratos M González Cuesta | | 2022 |
| This journal is© The Royal Society of Chemistry 2019 M González-Cuesta, D Goyard, E Nanba, K Higaki, JM García | | |